Search

everythinglearnresearchcommunity

for

Search:↓

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Finasteride helps reduce blood vessel growth in diabetic rat kidneys.

Low ferritin levels can indicate iron deficiency as a cause of hair loss.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Finasteride and metformin both help treat PCOS, but using them together works best.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

A young woman's rare ovarian tumor was successfully removed, improving her hormonal symptoms.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Androgens significantly affect female hair loss, and hormonal treatments may help.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Hirsutism causes significant psychological distress in women.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Endovascular repair and open surgery for abdominal aortic aneurysms both result in a temporary decline in physical health, with no significant mental health difference, and a return to near normal health in 90 days.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.